Wockhardt Limited (BOM:532300)
India · Delayed Price · Currency is INR 1,407.40
+2.00 (0.14%)
At close: Apr 21, 2026
Wockhardt Market Cap
Wockhardt has a market cap or net worth of 228.74 billion as of April 21, 2026. Its market cap has decreased by -0.10% in one year.
Market Cap
228.74B
Enterprise Value
246.61B
Revenue
31.74B
Ranking
n/a
PE Ratio
1,039.73
Stock Price
1,407.40
Market Cap Chart
Since February 21, 2001, Wockhardt's market cap has increased from 17.40B to 228.74B, an increase of 1,214.31%. That is a compound annual growth rate of 10.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 228.74B | -2.66% |
| Dec 31, 2025 | 235.00B | 2.08% |
| Dec 31, 2024 | 230.20B | 276.45% |
| Dec 29, 2023 | 61.15B | 90.30% |
| Dec 30, 2022 | 32.13B | -29.77% |
| Dec 31, 2021 | 45.75B | -24.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 548.17B |
| GlaxoSmithKline Pharmaceuticals | 412.01B |
| J. B. Chemicals & Pharmaceuticals | 320.69B |
| AstraZeneca Pharma India | 212.72B |
| Granules India | 162.16B |
| Rubicon Research | 148.09B |
| Jubilant Pharmova | 144.39B |
| Caplin Point Laboratories | 134.73B |